← All diseases Rare and hereditary disorders

Hereditary ATTR amyloidosis

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchOnly the strongest evidence (80)Meta-analysis (11)Treatment guideline (1)Phase 3 study (30)Randomized trial (23)Systematic review (15)Clinical trial (344)Review article (146)Early study (phase 1 or 2) (7)Case report (135)Laboratory or animal study (8)Commentary or editorial (72) Studies currently recruiting participants only (35)

Filter

Publications (1019)

• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Inotersen for the Treatment of Hereditary Transthyretin Amyloidosis. (2020/01/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. A Statement on the Appropriate Administration of Tafamidis in Patients With Transthyretin Cardiac Amyloidosis. (2019/12/25) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Recent advances in the treatment of chronic heart failure. (2019/12/20) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Association of the V122I Hereditary Transthyretin Amyloidosis Genetic Variant With Heart Failure Among Individuals of African or Hispanic/Latino Ancestry. (2019/12/10) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Gastrointestinal Manifestations in Hereditary Transthyretin Amyloidosis associated with Glu89Gln Mutation. (2019/12/09) ♡
• Transthyretin Anti-Amyloidogenic and Fibril Disrupting Activities of Bacopa monnieri (L.) Wettst (Brahmi) Extract. (2019/12/09) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Amyloid and the Heart. (2019/12/03) ♡
• Founder effect of the Glu89Gln TTR mutation in the Bulgarian population. (2019/12/01) ♡
• A comprehensive safety profile of tafamidis in patients with transthyretin amyloid polyneuropathy. (2019/12/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Pharyngo-laryngeal involvement in systemic amyloidosis with cardiac involvement: a prospective observational study. (2019/12/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Association between hearing loss and hereditary ATTR amyloidosis. (2019/12/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Prevalence of TTR variants detected by whole-exome sequencing in hypertrophic cardiomyopathy. (2019/12/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Transthyretin Cardiac Amyloidosis Due to Homozygous Val122Ile Mutation in a Caucasian Man. (2019/12/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. An evaluation of patisiran: a viable treatment option for transthyretin-related hereditary amyloidosis. (2019/12/01) ♡
• Plasma neurofilament light chain concentration is increased and correlates with the severity of neuropathy in hereditary transthyretin amyloidosis. (2019/12/01) ♡
• Phenome-wide association study of TTR and RBP4 genes in 361,194 individuals reveals novel insights in the genetics of hereditary and wildtype transthyretin amyloidoses. (2019/12/01) ♡
• Transthyretin Cardiac Amyloidosis as Diagnosed by 99mTc-PYP Scanning in Patients with Acute Heart Failure and Preserved Ejection Fraction. (2019/12/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Blood pressure and orthostatic hypotension as measures of autonomic dysfunction in patients from the transthyretin amyloidosis outcomes survey (THAOS). (2019/12/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. HFpEF: an enigma being slowly but surely unravelled. (2019/12/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. No Association Between CHADS-VASc Score and Left Atrial Appendage Thrombus in Patients With Transthyretin Amyloidosis. (2019/12/01) ♡
• Tafamidis: a selective transthyretin stabilizer to treat wild-type ATTR amyloidosis and hereditary ATTR amyloidosis with cardiomyopathy. (2019/12/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Sporadic Cardiac Amyloidosis by Amyloidogenic Transthyretin V122I Variant. (2019/11/30) ♡
• Clinical characteristics and prognosis of Chinese patients with hereditary transthyretin amyloid cardiomyopathy. (2019/11/12) ♡
• Clinicopathological correlations of sural nerve biopsies in TTR Val30Met familial amyloid polyneuropathy. (2019/11/04) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Where Neurosurgery Meets Heart Failure: A Case Report of a Patient with Amyloid Transthyretin Wild Type in the Ligamentum Flavum and Cardiac Tissue with Bilateral Carpal Tunnel Syndrome. (2019/11/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Myocardial Amyloidosis: The Exemplar Interstitial Disease. (2019/11/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Cardiac devices in patients with transthyretin amyloidosis: Impact on functional class, left ventricular function, mitral regurgitation, and mortality. (2019/11/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Perspectives, issues and solutions in RNAi therapy: the expected and the less expected. (2019/11/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Severe hand pain as an extracardiac manifestation of transthyretin amyloidosis. (2019/10/23) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Development of measures of polyneuropathy impairment in hATTR amyloidosis: From NIS to mNIS + 7. (2019/10/15) ♡
• Natural history and long-term effects of variant protein reduction in non-V30M ATTR amyloidosis. (2019/10/15) ♡
• Amyloid cardiomyopathy in a large integrated health care system. (2019/10/01) ♡
• Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Diagnostic performance of imaging investigations in detecting and differentiating cardiac amyloidosis: a systematic review and meta-analysis. (2019/10/01) ♡
• Biophysical characterization and modulation of Transthyretin Ala97Ser. (2019/10/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Impact of Genetic Testing in Transthyretin (ATTR) Cardiac Amyloidosis. (2019/10/01) ♡
• Current approaches for treatment of hereditary transthyretin amyloidosis (ATTR). (2019/10/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Patisiran's path to approval as an RNA therapy. (2019/10/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Neuropathy Associated with Systemic Amyloidosis. (2019/10/01) ♡
• Prevalence of hereditary transthyretin amyloid polyneuropathy in idiopathic progressive neuropathy in conurban areas. (2019/09/18) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Estimating the fiscal impact of rare diseases using a public economic framework: a case study applied to hereditary transthyretin-mediated (hATTR) amyloidosis. (2019/09/18) ♡
• Noninvasive Mapping of the Electrophysiological Substrate in Cardiac Amyloidosis and Its Relationship to Structural Abnormalities. (2019/09/17) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Advances in the treatment of hereditary transthyretin amyloidosis: A review. (2019/09/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Novel RNA-targeted therapies for hereditary ATTR amyloidosis and their impact on the autonomic nervous system. (2019/09/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Tafamidis for autonomic neuropathy in hereditary transthyretin (ATTR) amyloidosis: a review. (2019/09/01) ♡
• New Drugs Treat Rare Heart Disease Caused by Transthyretin-Mediated Amyloidosis. (2019/09/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Orthostatic hypotension in hereditary transthyretin amyloidosis: epidemiology, diagnosis and management. (2019/09/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Diagnosis and treatment of gastrointestinal dysfunction in hereditary TTR amyloidosis. (2019/09/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Diagnosis and treatment of heart failure in hereditary transthyretin amyloidosis. (2019/09/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Diagnosis and treatment of urinary and sexual dysfunction in hereditary TTR amyloidosis. (2019/09/01) ♡
• Phenotypes of Late-Onset Transthyretin Amyloid Neuropathy: A Diagnostic Challenge. (2019/09/01) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.